Bovie Medical Co. (BVX) Reaches New 52-Week High at $2.65
Bovie Medical Co. (NYSE:BVX)’s share price hit a new 52-week high on Wednesday . The stock traded as high as $2.65 and last traded at $2.57, with a volume of 183,974 shares trading hands. The stock had previously closed at $2.38.
Several equities analysts recently weighed in on the company. JMP Securities restated an “outperform” rating and issued a $5.00 price target on shares of Bovie Medical in a research note on Wednesday. Zacks Investment Research upgraded Bovie Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, May 18th.
The stock’s market cap is $70.33 million. The stock has a 50 day moving average of $1.79 and a 200-day moving average of $1.83.
Bovie Medical (NYSE:BVX) last released its quarterly earnings data on Wednesday, May 11th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.02. The business had revenue of $7.80 million for the quarter, compared to the consensus estimate of $7.17 million. On average, equities analysts anticipate that Bovie Medical Co. will post ($0.13) earnings per share for the current year.
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.